grant

Cancer Therapeutics Program

Organization ALBERT EINSTEIN COLLEGE OF MEDICINELocation BRONX, UNITED STATESPosted 1 Jun 1997Deadline 30 Jun 2028
NIHUS FederalResearch GrantFY2025Anti-Cancer AgentsAntineoplastic AgentsAntineoplastic DrugsAntineoplasticsBioinformaticsBiological AgentBiological ProductsCCSGCTEPCancer CenterCancer Center Support GrantCancer DrugCancer Therapy Evaluation ProgramCancer TreatmentCancersCatchment AreaCenter for Cancer ResearchClinicalClinical InvestigatorClinical TrialsCollaborationsComprehensive Cancer CenterConduct Clinical TrialsCredentialingDevelopmentDevelopmental TherapeuticsDevelopmental Therapeutics ProgramDevelopmental TherapyDiseaseDisorderDoctor of PhilosophyEarly DiagnosisGoalsHumanInterdisciplinary ResearchInterdisciplinary StudyInvestigatorsLaboratoriesMalignant Neoplasm TherapyMalignant Neoplasm TreatmentMalignant NeoplasmsMalignant TumorMentorsMissionModern ManMolecularMultidisciplinary CollaborationMultidisciplinary ResearchNCI Center for Cancer ResearchNeoplastic Disease Chemotherapeutic AgentsOrganOutcomePh.D.PhDPharmaceutical AgentPharmaceuticalsPharmacologic SubstancePharmacological SubstancePhasePreventionPrincipal InvestigatorResearchResearch PersonnelResearchersResistanceResource SharingScienceScientistTherapeuticTranslatingTranslationsTreatment ProtocolsTreatment RegimenTreatment ScheduleTumor-Specific Treatment AgentsVariantVariationanti-cancer druganti-cancer researchanti-cancer therapybiologicsbiopharmaceuticalbiotherapeutic agentcancer pharmacologycancer researchcancer therapycancer-directed therapyclinical developmentdesigndesigningdevelopmentaldrug developmentearly detectionimprovedinnovateinnovationinnovativeinterestmalignancymemberneoplasm/cancernew anti-cancer agentnew anticancer agentnew anticancer drugnew antineoplasticnew cancer drugnew drug treatmentsnew drugsnew pharmacological therapeuticnew therapeuticsnew therapynext generation therapeuticsnovelnovel anti-cancer agentnovel anti-cancer drugnovel anticancer agentnovel anticancer drugnovel antineoplasticnovel cancer drugnovel drug treatmentsnovel drugsnovel pharmaco-therapeuticnovel pharmacological therapeuticnovel therapeuticsnovel therapypharmaceuticalpre-clinicalpre-clinical developmentpreclinicalpreclinical developmentprogramsrecruitresistantsmall moleculetranslationtranslational investigatortranslational researchertranslational scientisttumor
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

CANCER THERAPEUTICS PROGRAM - PROJECT SUMMARY/ABSTRACT
Significant advances have been made in the development of novel agents and combination regimens for the treatment of human cancers. Despite this progress, major research efforts are still needed to develop new drugs to improve anticancer therapy and overcome resistance to current therapies.…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →